Literature DB >> 16288051

Diminished expression of transcription factors nuclear factor kappaB and CCAAT/enhancer binding protein underlies a novel tumor evasion mechanism affecting macrophages of mammary tumor-bearing mice.

Marta Torroella-Kouri1, Xiaojing Ma, Giselle Perry, Milena Ivanova, Pedro J Cejas, Jennifer L Owen, Vijaya Iragavarapu-Charyulu, Diana M Lopez.   

Abstract

Interactions between malignant tumors and the host immune system shape the course of cancer progression. The molecular basis of such interactions is the subject of immense interest. Proinflammatory cytokines produced by macrophages are critical mediators of immune responses that contribute to the control of the advancement of neoplasia. We have shown that the expressions of interleukin 12 (IL-12) and inducible nitric oxide synthase (iNOS) are decreased in macrophages from mammary tumor-bearing mice. In this study, we investigated the causes of IL-12 dysregulation and found deficient nuclear factor kappaB (NFkappaB) and CCAAT/enhancer binding protein (C/EBP) expression and function in tumor bearers' peritoneal macrophages. The constitutive expressions of NFkappaB p50, c-rel, p65, and C/EBPalpha and beta, as well as the lipopolysaccharide-induced nuclear translocation and DNA binding of NFkappaB components and C/EBPalpha and beta, are profoundly impaired in macrophages from mice bearing D1-DMBA-3 tumors. Because similar findings occur with the iNOS gene, it seems that it represents a novel mechanism by which tumor-derived factors interfere with the host immune defenses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288051      PMCID: PMC2963077          DOI: 10.1158/0008-5472.CAN-05-0365

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression.

Authors:  M Dlaska; G Weiss
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

2.  IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation.

Authors:  Toby Lawrence; Magali Bebien; George Y Liu; Victor Nizet; Michael Karin
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

3.  Cytokine production by lymphoreticular cells from mammary tumor bearing mice: the role of tumor-derived factors.

Authors:  D M Lopez; M E Handel-Fernandez; X Cheng; V Charyulu; L M Herbert; M R Dinapoli; C L Calderon
Journal:  Anticancer Res       Date:  1996 Nov-Dec       Impact factor: 2.480

4.  A novel function of IL-12p40 as a chemotactic molecule for macrophages.

Authors:  S J Ha; C H Lee; S B Lee; C M Kim; K L Jang; H S Shin; Y C Sung
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

5.  Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins.

Authors:  S E Plevy; J H Gemberling; S Hsu; A J Dorner; S T Smale
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

6.  Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression.

Authors:  H K Wong; G M Kammer; G Dennis; G C Tsokos
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

7.  Down-regulation of IL-12, not a shift from a T helper-1 to a T helper-2 phenotype, is responsible for impaired IFN-gamma production in mammary tumor-bearing mice.

Authors:  M E Handel-Fernandez; X Cheng; L M Herbert; D M Lopez
Journal:  J Immunol       Date:  1997-01-01       Impact factor: 5.422

8.  Phosphatidyl serine is involved in the reduced rate of transcription of the inducible nitric oxide synthase gene in macrophages from tumor-bearing mice.

Authors:  M R DiNapoli; C L Calderon; D M Lopez
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

9.  Diminished PKC activity and decreased binding of transcription factors are involved in the impaired production of nitric oxide by macrophages from tumor-bearing mice.

Authors:  Michael R Di Napoli; Marta Torroella-Kouri; Giselle Perry; Diana M Lopez
Journal:  Int J Mol Med       Date:  2005-03       Impact factor: 4.101

Review 10.  Immunologic dysfunction in cancer.

Authors:  D Y Kavanaugh; D P Carbone
Journal:  Hematol Oncol Clin North Am       Date:  1996-08       Impact factor: 3.722

View more
  11 in total

1.  Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors.

Authors:  Hiroaki Shime; Misako Matsumoto; Hiroyuki Oshiumi; Shinya Tanaka; Akio Nakane; Yoichiro Iwakura; Hideaki Tahara; Norimitsu Inoue; Tsukasa Seya
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-19       Impact factor: 11.205

Review 2.  Alterations in macrophages and monocytes from tumor-bearing mice: evidence of local and systemic immune impairment.

Authors:  Marta Torroella-Kouri; Dayron Rodríguez; Raul Caso
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 3.  Tumor-associated macrophages: functional diversity, clinical significance, and open questions.

Authors:  Subhra K Biswas; Paola Allavena; Alberto Mantovani
Journal:  Semin Immunopathol       Date:  2013-05-09       Impact factor: 9.623

4.  Tumor microenvironment profoundly modifies functional status of macrophages: peritoneal and tumor-associated macrophages are two very different subpopulations.

Authors:  Dayron Rodríguez; Risset Silvera; Roberto Carrio; Mehrdad Nadji; Raul Caso; Gracielena Rodríguez; Vijaya Iragavarapu-Charyulu; Marta Torroella-Kouri
Journal:  Cell Immunol       Date:  2013-06-19       Impact factor: 4.868

5.  Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor.

Authors:  Kavitha Yaddanapudi; Kalyani Putty; Beatriz E Rendon; Gwyneth J Lamont; Jonathan D Faughn; Abhay Satoskar; Amanda Lasnik; John W Eaton; Robert A Mitchell
Journal:  J Immunol       Date:  2013-02-06       Impact factor: 5.422

6.  Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians.

Authors:  Tulay Koru-Sengul; Ana M Santander; Feng Miao; Lidia G Sanchez; Merce Jorda; Stefan Glück; Tan A Ince; Mehrad Nadji; Zhibin Chen; Manuel L Penichet; Margot P Cleary; Marta Torroella-Kouri
Journal:  Breast Cancer Res Treat       Date:  2016-06-09       Impact factor: 4.872

7.  Paracrine Interactions between Adipocytes and Tumor Cells Recruit and Modify Macrophages to the Mammary Tumor Microenvironment: The Role of Obesity and Inflammation in Breast Adipose Tissue.

Authors:  Ana M Santander; Omar Lopez-Ocejo; Olivia Casas; Thais Agostini; Lidia Sanchez; Eduardo Lamas-Basulto; Roberto Carrio; Margot P Cleary; Ruben R Gonzalez-Perez; Marta Torroella-Kouri
Journal:  Cancers (Basel)       Date:  2015-01-15       Impact factor: 6.639

Review 8.  RNA Activation-A Novel Approach to Therapeutically Upregulate Gene Transcription.

Authors:  Choon Ping Tan; Laura Sinigaglia; Valentí Gomez; Joanna Nicholls; Nagy A Habib
Journal:  Molecules       Date:  2021-10-28       Impact factor: 4.411

9.  Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy.

Authors:  Carly Bess Williams; Elizabeth S Yeh; Adam C Soloff
Journal:  NPJ Breast Cancer       Date:  2016-01-20

Review 10.  Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors.

Authors:  Jack A Prescott; Simon J Cook
Journal:  Cells       Date:  2018-08-23       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.